206 T. Matsuo and K. Izumori [6] Matsuo, T., Tanaka, T., Hashiguchi, M., Izumori, K., and Suzuki, H.: Effects of oral acute administration and sub- chronic feeding of several levels of D-psicose in rats. J. Nutr. Sci. Vitaminol., 48, 512–516, 2002. [7] Matsuo, T., Tanaka, T., Hashiguchi, M., Izumori, K., and Suzuki, H.: Metabolic effects of D-psicose in rats: studies on faecal and urinary excretion and caecal fermentation. Asia Pacific J. Clin. Nutr., 12, 225–231, 2003. [8] The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent-diabetes mellitus. N. Engl. J. Med., 329, 977–986, 1993. [9] Toeller, M.: Nutritional recommendations for diabetic patients and treatment with α-glucosidase inhibitors. Drugs, 44 Suppl. 3, 13–20, 1992. [10] Lebovitz, H.E.: Oral antidiabetic agents: The emergence of α-glucosidase inhibitors. Drugs, 44 Suppl. 3, 21–28, 1992. [11] Puls, W., Keup, U., and Krause, H.P.: Glucosidase inhibition: A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften, 64, 536–537, 1977. [12] Caspary, W.F. and Graf, S.: Inhibition of human intestinal α- glucosidase hydrolases by a new complex oligosaccharide. Res. Exp. Med., 175, 1–6, 1979. [13] Puls, W., Keup, U., and Krause, H.P.: Pharmacology of α- glucosidase inhibitor. Front Horm. Res., 7, 235–247, 1980. [14] Seri, K., Sanai, K., Matsuo, N., Kawakubo, K., Xue, C., and Inoue, S.: L-Arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism, 45, 1368– 1374, 1996. [15] Sanai, K., Seri, K., and Inoue, S.: Inhibition of sucrose diges- tion and absorption by L-arabinose in rats. J. Jpn. Soc. Nutr. Food Sci., 50, 133–137, 1997. [16] Hizukuri, S.: Nutritional and physiological functions and uses of L-arabinose. J. Appl. Glycosci., 45, 159–165, 1999. [17] Inoue, S., Sanai, K., and Seri, K.: Effect of L-arabinose on blood glucose level after ingestion of sucrose-containing food in human. J. Jpn. Soc. Nutr. Food Sci., 53, 243–247, 2000. [18] Matsuo, T. and Izumori, K.: Effects of supplemental D- psicose on glucose tolerance and serum adipocytokine levels in rats fed a high-fat diet or a low-fat diet. J. Oleo. Sci., 53, 453–460, 2004. [19] Matsuo, T.: Inhibitory effects of D-psicose on glycemic responses after oral carbohydrate tolerance test in rats. J. Jpn. Soc. Nutr. Food Sci., 59, 119–121, 2006. [20] Matsuo, T. and Izumori, K.: Effects of dietary D-psicose on diurnal variation in plasma glucose and insulin concentra- tions of rats. Biosci. Biotechnol. Biochem., 70, 2081–2085, 2006. [21] Dahlqvist, A.: Intestinal disaccharidases. in Methods in Enzymology, vol. 8, Complex Carbohydrates, eds. By Neufeld, E.F., and Ginsburg, V., Academic Press, New York, pp. 584–951, 1966. [22] Whelan, W.J.: Hydrolysis with α-amylase. in Carbohydrate Chemistry, vol. 4, Starch, ed. By Whistler, R.L., Academic Press, New York, pp. 252–260, 1964. [23] Semenza, G. and Balthazar, A.K.: Steady-state kinetics of rabbit intestinal sucrase: Kinetic mechanism, Na+ activation, inhibition by Tris (hydroxymethyl) aminomethane at the glucose subsite. Eur. J. Biocem., 41, 149–162, 1974. [24] Miura, T., Koide, T., Ohichi, R., Kako, M., Usami, M., Ishihara, E., Yasuda, N., Ishida, H., Seino, Y., and Tanigawa, K.: Effect of acarbose (α-glucosidase inhibitor) on dis- accharase activity in small intestine in KK-Ay and ddY Mice. J. Nutr. Sci. Vitaminol., 44, 371–379, 1988. [25] Puls, W. and Keup, U.: Inhibition of sucrase by Tris in rats and man, demonstrated by oral loading tests with sucrose. Metabolism, 24, 93–98, 1975. [26] Cree, G.M. and Perlin, A.S.: O-Isopropylidene derivatives of D-allulose (D-psicose) and D-erythro-hexopyranose-2,3- diulose. Can. J. of Biochem., 46, 765–770, 1968. [27] Binkley, W.W.: The fate of cane juice simple sugars during molasses formation IV. Probable conversion of D-fructose to D-psicose. Int. Sugar J., 65, 105–106, 1963. [28] Miller, B.S. and Swain, T.: Chromatographic analyses of the free amino acids, organic acids and sugars in wheat plant extracts. J. Sci. Food Agric., 11, 344–348, 1960. [29] Hough, L. and Stacey, B.E.: Variation in the allitol content of Itea plants during photosynthesis. Phytochemistry, 5, 171– 175, 1966. [30] Eble, T.E., Hoeksema, H., Boyack, G.A., and Savage, G.M.: Psicofuranine. I. Discovery, isolation, and properties. Antibiot. Chemother., 9, 419–420, 1959. [31] The Ministry of Health and Welfare, Japan: Information on Adverse Reactions to Drugs. no. 129, Tokyo, Japan, pp. 2–3, 1994. [32] Kaiser, T. and Sawicki, P.T.: Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia, 47, 575– 580, 2004. [33] Van De Laar, F.A. and Lucassen, P.L.B.J.: No evidence for a reduction of myocardial infarctions by acarbose. Eur. Heart J., 25, 1179, 2004. [34] Van De Laar, F.A., Lucassen, P.L.B.J., Akkermans, R.P., Van De Lisdonk, E.H., Rutten, G.E., and Van Weel, C.: α- Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care, 28, 154–163, 2005. [35] Yagi, K. and Matsuo, T.: The study on long-term toxicity of D-psicose in rats. J. Clin. Biochem. Nutr., in press. J. Clin. Biochem. Nutr.